Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The major histocompatibility complex (MHC) is a large genomic region encoding cell surface proteins essential for the adaptive immune system. MHC molecules, also known as human leukocyte antigens (HLA) in humans, present peptide antigens to T cells, mediating immune recognition and response. The MHC region is highly polymorphic, contributing to diverse pathogen recognition. It is critical for tissue transplantation compatibility and is implicated in susceptibility/resistance to autoimmune diseases.
Immunosuppression; modulation of T-cell activation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major Histocompatibility Complex (MHC).